IRCT20231119060107N1尚未招募3 期
The Efficacy and side effects of oral dutasteride in the treatment of female pattern androgenetic alopecia compared with oral spironolactone in one sided clinical trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- Female
入选标准
- •?Androgenitic alopecia female patients
排除标准
- •History of breast cancer
- •Usage of another AGA treatment in the past 3 months
- •Pregnancy or a plan to get ptegnant in the next year
- •Smoking or alchohol addiction
- •Drug reaction to dutasteride or spironolactone
- •History of hair transplant
- •History of any dermatologic or systemic disease that affect hair
研究者
相似试验
已完成
3 期
The efficacy and safety of low-dose dutasteride versus finasteride in the treatment of male androgenetic alopeciaMale androgenetic alopecia (Hamilton-Norwood classification IIIvertex-V)FinasterideDutasterideMale androgenetic alopeciaLow-dose dutasterideHair countHair densityHair diameterVideodermoscopyGlobal photographyTCTR20221106001Faculty of Medicine, Srinakharinwirot University58
已完成
不适用
The clinical effects of dutasteride on the systemic bodyJPRN-UMIN000005173Departments of Urology, Kanazawa University Graduate School of Medical Science100
已完成
不适用
ong-term effect of dutasteride as add-on therapy for benign prostatic hyperplasia with persistent overactive bladder symptoms after treatment of alpha-1 blockerBenign prostatic hyperplasiaJPRN-UMIN000032082Hokkaido Prefectural Esashi Hospital70
已完成
不适用
Open labelled, single arm, interventional study of topical dutasteride lotion for androgenetic alopecia.CTRI/2022/04/041637CUTIS Academy of Cutaneous Sciences10
尚未招募
不适用
Study of absorption and elimination rate of Dutasteride capsules 0.5 mg in comparison with Dutasteride brand capsules (Avodart ®).IRCT20200407046981N33Zahravi pharmaceutical company24